Scientists test how cancer drug mixes with cholesterol pill
NCT ID NCT02197234
Summary
This study tested how a new lung cancer drug (AZD9291) affects the body's processing of a common cholesterol medication (simvastatin). Researchers enrolled 52 patients with advanced lung cancer that had stopped responding to standard treatments. The goal was to understand potential drug interactions to help doctors safely prescribe medications together in the future.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Atlanta, Georgia, 30322, United States
-
Research Site
Leuven, 3000, Belgium
-
Research Site
Angers, 49055, France
-
Research Site
Dijon, 21079, France
-
Research Site
Marseille, 13385, France
-
Research Site
Rennes, 35033, France
-
Research Site
Saint-Herblain, 44805, France
-
Research Site
Seongnam-si, 13620, South Korea
-
Research Site
Seoul, 03080, South Korea
-
Research Site
Seoul, 03722, South Korea
-
Research Site
Seoul, 05505, South Korea
-
Research Site
Seoul, 06351, South Korea
-
Research Site
Badalona, 08916, Spain
-
Research Site
Barcelona, 08041, Spain
-
Research Site
Madrid, 28046, Spain
-
Research Site
Seville, 41013, Spain
Conditions
Explore the condition pages connected to this study.